Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging

Hsiung, Ging-Yuek R.; Sadovnick, A. Dessa; Feldman, Howard
October 2004
CMAJ: Canadian Medical Association Journal;10/12/2004, Vol. 171 Issue 8, p863
Academic Journal
Background: Apolipoprotein E (ApoE) ε4 genotype is a well-established risk factor for Alzheimer's disease (AD). However, its effect on predicting conversion from normal to "cognitive impairment, no dementia" (CIND) and from CIND to AD is less clear. Methods: We used a nested case-control design from the population-based Canadian Study of Health and Aging (CSHA) to examine the effect of ApoE ε4 genotype on the conversion of subjects from normal to CIND and from CIND to AD. We also contrasted these findings with incident cases of AD and vascular dementia (VaD) in the CSHA cohort. Results: The ApoE ε4 genotype was a significant risk factor for conversion from CIND to AD and from normal to AD and VaD. However, it was not a significant risk factor for conversion from normal to CIND. This effect is robust to adjustment for age, sex and education level. There is significant interaction between the ApoE ε4 genotype and age for AD and for conversion from CIND to AD. No interaction between ApoE ε4 genotype, sex, age, ethnicity and education level was found in other subgroup analyses. The positive predictive value of ApoE ε4 for predicting CIND conversion to AD was 0.48, and the negative predictive value was 0.65. Interpretation: Possession of an ApoE ε4 allele increases the risk of AD developing from CIND. It is also associated with a decrease in the age at onset of AD. Its predictive values do not support its utility as a diagnostic test for predicting progression from CIND to AD, but it may be useful in research studies to enrich study samples that have a higher rate of progression to AD.


Related Articles

  • Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity. Panos, Stella E.; Hinkin, Charles H.; Singer, Elyse J.; Thames, April D.; Patel, Sapna M.; Sinsheimer, Janet S.; Del Re, A.C.; Gelman, Benjamin B.; Morgello, Susan; Moore, David J.; Levine, Andrew J. // Neurobehavioral HIV Medicine;2013, Vol. 5, p11 

    Background: The apolipoprotein-E (APOE) ε4 allele is a risk factor for vascular dementia and Alzheimer's disease. Recent studies are equivocal with regards to whether or not the ε4 allele confers increased risk for the development of human immunodeficiency virus (HIV)-associated...

  • Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition. Wierenga, Christina E; Dev, Sheena I; Shin, David D; Clark, Lindsay R; Bangen, Katherine J; Jak, Amy J; Rissman, Robert A; Liu, Thomas T; Salmon, David P; Bondi, Mark W // Journal of Cerebral Blood Flow & Metabolism;Aug2012, Vol. 32 Issue 8, p1589 

    Using whole-brain pulsed arterial spin labeling magnetic resonance imaging, resting cerebral blood flow (CBF) was measured in 20 mild cognitive impairment (MCI; 11 ɛ3 and 9 ɛ4) and 40 demographically matched cognitively normal (CN; 27 ɛ3 and 13 ɛ4) participants. An interaction of...

  • Protein Gene Modulates: ALZHEIMER'S DISEASE.  // Research at Penn;2011, Vol. 9, p7 

    The article discusses a study that reveals the association between the apolipoprotein E ε4 gene (APOE ε4) and Alzheimer's disease.

  • Apolipoprotein E ϵ4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease. Kivipelto, Mila; Helkala, Eeva-Liisa; Laakso, Mikko P.; Hänninen, Tuomo; Hallikainen, Merja; Alhainen, Kari; Iivonen, Susan; Mannermaa, Arto; Tuomilehto, Jaakko; Nissinen, Aulikki; Soininen, Hilkka // Annals of Internal Medicine;8/6/2002, Vol. 137 Issue 3, p149 

    Provides information regarding cholesterol metabolism as an important genetic risk factor for Alzheimer disease. Examines the relationship between cholesterol level and midlife blood pressure; Population-based study of 1449 persons 65-79 years of age; Discusses independent risk factors for...

  • Semantic memory activation in amnestic mild cognitive impairment. Woodard, J. L.; Seidenberg, M.; Nielson, K. A.; Antuono, P.; Guidotti, L.; Durgerian, S.; Zhang, Q.; Lancaster, M.; Hantke, N.; Butts, A.; Rao, S. M. // Brain: A Journal of Neurology;Aug2009, Vol. 132 Issue 8, p2068 

    Cognitively intact older individuals at risk for developing Alzheimers disease frequently show increased functional magnetic resonance imaging (fMRI) brain activation presumably associated with compensatory recruitment, whereas mild cognitive impairment (MCI) patients tend not to show increased...

  • Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. van Duijin, Cornelia M.; Hevekes, Louis M. // BMJ: British Medical Journal (International Edition);3/11/95, Vol. 310 Issue 6980, p627 

    Investigates the hypothesis that differential survival between smokers and nonsmokers leading to a decrease in the frequency of the e4 allele of the apolipoprotein E gene may explain the inverse relation between smoking history and early onset of Alzheimer's disease. Inverse association between...

  • Apolipoprotein E status as a risk factor for alzheimer's disease.  // Age & Ageing;Jan96 Supplement 1, Vol. 25, p35 

    Presents an abstract of the report `Apolipoprotein E status as a risk factor for alzheimer's disease,' by T.P. Smith et al, presented during the Autumn Meeting of the British Geriatrics Society on October 13 and 14, 1995 in London, England.

  • Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Artiga, M. J.; Bullido, M. J.; Frank, A.; Sastre, I.; Recuero, M.; García, M. A.; Lendon, C. L.; Han, S. W.; Morris, J. C.; Vázquez, J.; Goate, A.; Valdivieso, F. // Human Molecular Genetics;Nov98 Supplement, Vol. 7 Issue 12, p1887 

    Reveals that the risk for Alzheimer's disease (AD) correlates with transcriptional activity of the 4 allele of apolipoprotein E (APOE) gene. Association of ApOE with risk for late onset AD; Role of allelic variant and haplotype of the APOE promoter; Attribution of increased risks to the local...

  • Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. Fleminger, S.; Oliver, D.L.; Lovestone, S.; Rabe-Hesketh, S.; Giora, A. // Journal of Neurology, Neurosurgery & Psychiatry;Jul2003, Vol. 74 Issue 7, p857 

    Objective: To determine, using a systematic review of case-control studies, whether head injury is a significant risk factor for Alzheimer's disease. We sought to replicate the findings of the meta-analysis of Mortimer et al (1991). Methods: A predefined inclusion criterion specified...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics